Business

Holdings in Company

M&G Plc has increased its holding in Ondine Biomedical Inc. to 14.29% of the voting rights, crossing a 1% threshold. This change, effective March 16, 2026, represents a total of 74,268,775 voting rights. The previous notification showed a holding of 13.04%. The notification was made on March 17, 2026, and the increase is due to movements within M&G Plc's controlled undertakings. Disclaimer*

articleOndine Biomedical, Inc.March 24, 20265/company/ondine-biomedical-inc/news/holdings-in-company-1027
Holdings in Company

About this update from Ondine Biomedical, Inc.

[{"type":"text","content":"\n\nTR-1: Standard form for notification of major holdings\n\n1. Issuer Details\n\n\n\nISIN\n\n\nCA68234M2058\n\n\nIssuer Name\n\n\nONDINE BIOMEDICAL INC\n\n\nUK or Non-UK Issuer\n\n\nNon-UK\n\n\n\n2. Reason for Notification\n\n\n\nOther\n\n\nComments\n\n\nMovement of 1% as per Articles\n\n\n\n3. Details of person subject to the notification obligation\n\n\n\nName\n\n\nM&G Plc\n\n\nCity of registered office (if applicable)\n\n\nLondon\n\n\nCountry of registered office (if applicable)\n\n\nUnited Kingdom\n\n\n\n4. Details of the shareholder\n\n\n\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\n\n\n \n\n\nCity of registered office (if applicable)\n\n\n \n\n\nCountry of registered office (if applicable)\n\n\n \n\n\n\n5. Date on which the threshold was crossed or reached\n\n\n16-Mar-2026\n\n\n6. Date on which Issuer notified\n\n\n17-Mar-2026\n\n\n7. Total positions of person(s) subject to the notification obligation\n\n\n\n\n\n\n\n\n% of voting rights attached to shares (total of 8.A)\n\n\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\n\n\nTotal of both in % (8.A + 8.B)\n\n\nTotal number of voting rights held in issuer\n\n\n\n\nResulting situation on the date on which threshold was crossed or reached\n\n\n14.294787\n\n\n0.000000\n\n\n14.294787\n\n\n74268775\n\n\n\n\nPosition of previous notification (if applicable)\n\n\n13.041900\n\n\n0.000000\n\n\n13.041900\n\n\n\n\n\n\n\n\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n\n\n8A. Voting rights attached to shares\n\n\n\n\n\n\nClass/Type of shares ISIN code(if possible)\n\n\nNumber of direct voting rights (DTR5.1)\n\n\nNumber of indirect voting rights (DTR5.2.1)\n\n\n% of direct voting rights (DTR5.1)\n\n\n% of indirect voting rights (DTR5.2.1)\n\n\n\n\nCA68234M2058\n\n\n\n\n\n74268775\n\n\n\n\n\n14.294787\n\n\n\n\nSub Total 8.A\n\n\n74268775\n\n\n14.294787%\n\n\n\n\n\n\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\n\n\n\n\n\n\nType of financial instrument\n\n\nExpiration date\n\n\nExercise/conversion period\n\n\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n\n\n% of voting rights\n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSub Total 8.B1\n\n\n\n\n\n\n\n\n\n\n\n\...

More updates from Ondine Biomedical, Inc.